Biognosys is using a method developed by ETHZ researchers for the unbiased detection of molecular targets based on protein-metabolite interactions to study inter- and intra-patient variances in the proteome. The protein services CRO will also...

Thanks to a well-planned robust pivotal trial and a dose of good timing, Cologuard from Exact Sciences Corp. is enjoying one of the steepest launch trajectories of any molecular diagnostic. After 10 quarters of sales,...